Advertisement
Screener

Co-Diagnostics, Inc. (CODX) EBITDA

Co-Diagnostics, Inc. (CODX) EBITDA

  • 2026-06-30: Basis Reported; EBITDA (m); Operating income -$6.20M; Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA (m); Operating income -$9.21M; Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$6.75M*; Operating income -$7.01M; Depreciation and amortization $267.38K*.
  • 2025-06-30: Basis Reported; EBITDA -$7.77M*; Operating income -$8.06M; Depreciation and amortization $291.41K*.

Complete source-backed ebitda history.

Available history
2016-06-30 to 2025-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)-$6.20M(m)$166.13K(m)$18.28K*-$7.15M*(m)$4.15M(m)$19.17K
2026-03-31Reported(m)-$9.21M(m)$145.95K(m)$142.02K-$7.85M(m)$5.93M(m)$520.00
2025-09-30Reported-$6.75M*-$7.01M$267.38K*$145.38K-4640.57%*$75.11K*-$5.90M*(m)$4.48M(m)-$1.17M
2025-06-30Reported-$7.77M*-$8.06M$291.41K*$162.91K-4767.26%*$401.06K*-$8.29M*(m)$4.69M(m)$12.33K
2025-03-31Reported-$8.27M(m)(m)(m)-16451.88%$91.91K-$8.75M(m)$4.87M(m)$12.00K
2024-12-31Reported-$11.55M(m)(m)(m)-7734.74%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$9.88M*-$10.23M$351.24K*$641.14K-1541.58%*$174.44K*-$7.23M*(m)$4.88M(m)$22.19K
2024-06-30Reported-$7.34M*-$7.68M$338.33K*$2.66M-276.33%*$98.63K*-$5.20M*(m)$5.61M(m)$20.59K
2024-03-31Reported-$9.93M(m)(m)(m)-2122.20%$402.29K-$8.49M(m)$5.68M(m)$22.76K
2023-12-31Reported-$11.51M(m)(m)(m)-323.82%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$8.64M*-$8.94M$296.34K*$2.46M-351.62%*$236.57K*-$5.77M*(m)$5.79M(m)-$2.11M
2023-06-30Reported-$11.69M*-$11.99M$305.25K*$197.81K-5909.42%*$484.19K*-$5.62M*(m)$5.98M(m)-$2.24M
2023-03-31Reported-$9.63M(m)(m)(m)-1600.55%$179.94K-$5.92M(m)$5.01M(m)-$2.26M
2022-12-31Reported-$25.82M(m)(m)(m)-1842.53%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$6.22M*-$6.54M$312.49K*$5.09M-122.15%*$230.05K*$1.12M*(m)$5.04M(m)-$2.11M
2022-06-30Reported-$3.72M*-$4.15M$424.34K*$5.02M-74.11%*$507.56K*$1.65M*(m)$3.89M(m)-$741.51K
2022-03-31Reported$10.07M(m)(m)(m)44.37%$396.60K$7.81M(m)$3.77M(m)$1.39M
2021-12-31Reported$10.41M(m)(m)(m)51.03%(m)(m)(m)(m)(m)(m)
2021-09-30Reported$13.72M(m)(m)(m)45.59%$165.73K*$11.51M*(m)$5.89M(m)$2.10M
2021-06-30Reported$11.86M(m)(m)(m)43.36%$242.42K*$12.42M*(m)$4.67M(m)$2.15M
2021-03-31Reported$10.4M(m)(m)(m)51.95%$139.56K$12.27M(m)$2.22M(m)$1.99M
2020-12-31Reported$16.09M(m)(m)(m)59.26%(m)(m)(m)(m)(m)(m)
2020-09-30Reported$12.07M(m)(m)(m)55.34%$100.39K*$8.56M*(m)$921.89K(m)-$2.91M
2020-06-30Reported$14.73M(m)(m)(m)61.29%$104.92K*$987.07K*(m)$750.25K(m)(m)
2020-03-31Reported-$1.06M(m)(m)(m)-68.53%$100.37K-$1.34M(m)$400.02K(m)(m)
2019-12-31Reported-$1.6M(m)(m)(m)-1477.69%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$1.63M(m)(m)(m)-3941.40%$24.25K*-$1.22M*(m)$331.03K(m)(m)
2019-06-30Reported-$1.35M(m)(m)(m)-2191.95%(m)-$1.33M*(m)$312.59K(m)(m)
2019-03-31Reported-$1.24M(m)(m)(m)-36494.82%(m)-$1.37M(m)$347.31K(m)(m)
2018-12-31Reported-$1.81M(m)(m)(m)-16724.74%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$1.65M(m)(m)(m)-17029.22%-$7.19K*-$1.18M*(m)$330.42K(m)(m)
2018-06-30Reported-$1.34M(m)(m)(m)-13827.88%$1.00*-$967.97K*(m)$357.89K(m)(m)
2018-03-31Reported-$1.27M(m)(m)(m)-13046.91%$9.69K-$968.52K(m)$297.42K(m)(m)
2017-12-31Reported-$1.48M(m)(m)(m)-57011.55%(m)(m)(m)(m)(m)(m)
2017-09-30Reported-$1.79M(m)(m)(m)-69000.92%$3.35K*-$1.55M*(m)$272.21K(m)(m)
2017-06-30Reported-$689,866.00(m)(m)(m)-27975.10%$46.56K*-$247.87K*(m)$184.88K(m)(m)
2017-03-31Reported-$554,639.00(m)(m)(m)(m)$41.05K-$419.74K(m)$265.69K(m)(m)
2016-12-31Reported-$436,552.00(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-09-30Reported-$385,057.00(m)(m)(m)(m)$0.00*-$298.06K*(m)$172.80K(m)(m)
2016-06-30Reported-$381,431.00(m)(m)(m)(m)(m)(m)(m)$172.11K(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported(m)-$50.17M(m)$622.49K(m)$700.05K-$29.14M(m)$19.14M(m)-$1.62M
2024-12-31Reported-$38.7M(m)(m)(m)-988.57%$748.35K-$29.16M(m)$20.98M(m)$57.37K
2023-12-31Reported-$41.48M(m)(m)(m)-608.86%$1.37M-$22.08M(m)$22.96M(m)-$2.78M
2022-12-31Reported-$25.7M(m)(m)(m)-75.10%$1.43M$6.57M(m)$17.44M(m)-$4.61M
2021-12-31Reported$46.4M(m)(m)(m)47.40%$669.46K$41.08M(m)$14.96M(m)$8.98M
2020-12-31Reported$41.83M(m)(m)(m)56.11%$774.40K$28.17M(m)$3.19M(m)$90.54K
2019-12-31Reported-$5.83M(m)(m)(m)-2710.95%$113.25K-$5.53M(m)$1.37M(m)(m)
2018-12-31Reported-$6.07M(m)(m)(m)-15201.45%$41.34K-$4.08M(m)$1.36M(m)(m)
2017-12-31Reported-$4.52M(m)(m)(m)-58970.36%$129.31K-$3.21M(m)$1.00M(m)(m)
2016-12-31Reported-$1.65M(m)(m)(m)(m)$12.24K-$1.31M(m)$731.47K(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01